ABSTRACT
Aprataxin (APTX) deficiency causes progressive cerebellar degeneration, ataxia and oculomotor apraxia in man. Cell free assays and crystal structure studies demonstrate a role for APTX in resolving 5'-adenylated nucleic acid breaks, however, APTX function in vertebrates remains unclear due to the lack of an appropriate model system. Here, we generated a murine model in which a pathogenic mutant of superoxide dismutase 1 (SOD1(G93A)) is expressed in an Aptx-/- mouse strain. We report a delayed population doubling and accelerated senescence in Aptx-/- primary mouse fibroblasts, which is not due to detectable telomere instability or cell cycle deregulation but is associated with a reduction in transcription recovery following oxidative stress. Expression of SOD1(G93A) uncovers a survival defect ex vivo in cultured cells and in vivo in tissues lacking Aptx. The surviving neurons feature numerous and deep nuclear envelope invaginations, a hallmark of cellular stress. Furthermore, they possess an elevated number of high-density nuclear regions and a concomitant increase in histone H3 K9 trimethylation, hallmarks of silenced chromatin. Finally, the accelerated cellular senescence was also observed at the organismal level as shown by down-regulation of insulin-like growth factor 1 (IGF-1), a hallmark of premature ageing. Together, this study demonstrates a protective role of Aptx in vivo and suggests that its loss results in progressive accumulation of DNA breaks in the nervous system, triggering hallmarks of premature ageing, systemically.
Subject(s)
Aging, Premature/metabolism , DNA-Binding Proteins/deficiency , Motor Neurons/pathology , Nuclear Proteins/deficiency , Superoxide Dismutase/genetics , Transcription, Genetic/drug effects , Aging, Premature/genetics , Aging, Premature/pathology , Animals , Cells, Cultured , Cellular Senescence/drug effects , Disease Models, Animal , Humans , Hydrogen Peroxide/pharmacology , Insulin-Like Growth Factor I/metabolism , Mice , Mutation , Oxidative Stress , Superoxide Dismutase/metabolism , Superoxide Dismutase-1ABSTRACT
Many peptides self-assemble to form amyloid fibrils. We previously explored the sequence propensity to form amyloid using variants of a designed peptide with sequence KFFEAAAKKFFE. These variant peptides form highly stable amyloid fibrils with varied lateral assembly and are ideal to template further assembly of non-proteinaceous material. Herein, we show that the fibrils formed by peptide variants can be coated with a layer of silica to produce silica nanowires using tetraethyl-orthosilicate. The resulting nanowires were characterized using electron microscopy (TEM), X-ray fiber diffraction, FTIR and cross-section EM to reveal a nanostructure with peptidic core. Lysine residues play a role in templating the formation of silica on the fibril surface and, using this library of peptides, we have explored the contributions of lysine as well as arginine to silica templating, and find that sequence plays an important role in determining the physical nature and structure of the resulting nanowires.
Subject(s)
Amyloid/chemistry , Nanowires/chemistry , Peptides/chemistry , Silicon Dioxide/chemistry , Models, Molecular , Particle SizeABSTRACT
Tau is known for its pathological role in neurodegenerative diseases, including Alzheimer's disease (AD) and other tauopathies. Tau is found in many subcellular compartments such as the cytosol and the nucleus. Although its normal role in microtubule binding is well established, its nuclear role is still unclear. Here, we reveal that tau localises to the nucleolus in undifferentiated and differentiated neuroblastoma cells (SHSY5Y), where it associates with TIP5, a key player in heterochromatin stability and ribosomal DNA (rDNA) transcriptional repression. Immunogold labelling on human brain sample confirms the physiological relevance of this finding by showing tau within the nucleolus colocalises with TIP5. Depletion of tau results in an increase in rDNA transcription with an associated decrease in heterochromatin and DNA methylation, suggesting that under normal conditions tau is involved in silencing of the rDNA. Cellular stress induced by glutamate causes nucleolar stress associated with the redistribution of nucleolar non-phosphorylated tau, in a similar manner to fibrillarin, and nuclear upsurge of phosphorylated tau (Thr231) which doesn't colocalise with fibrillarin or nucleolar tau. This suggests that stress may impact on different nuclear tau species. In addition to involvement in rDNA transcription, nucleolar non-phosphorylated tau also undergoes stress-induced redistributionĀ similar to many nucleolar proteins.
Subject(s)
Cell Nucleolus/drug effects , Cell Nucleolus/metabolism , Excitatory Amino Acid Agonists/pharmacology , Gene Expression Regulation, Neoplastic/drug effects , Glutamic Acid/pharmacology , tau Proteins/metabolism , Brain/metabolism , Brain/ultrastructure , Cell Differentiation/physiology , Cell Line, Tumor , Cell Nucleolus/ultrastructure , Chromosomal Proteins, Non-Histone/metabolism , Chromosomal Proteins, Non-Histone/ultrastructure , DNA, Ribosomal/genetics , DNA, Ribosomal/metabolism , Gene Expression Regulation, Neoplastic/genetics , Heterochromatin/physiology , Histones/metabolism , Humans , Immunoprecipitation , Microscopy, Confocal , Microscopy, Electron , Neuroblastoma/pathology , Neuroblastoma/ultrastructure , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Protein Transport/drug effects , RNA, Messenger , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Transcription, Genetic/drug effects , Transfection , tau Proteins/genetics , tau Proteins/ultrastructureABSTRACT
Parkinson's disease (PD) is characterized by intracellular, insoluble Lewy bodies composed of highly stable α-synuclein (α-syn) amyloid fibrils. α-synuclein is an intrinsically disordered protein that has the capacity to assemble to form Ć-sheet rich fibrils. Oxidiative stress and metal rich environments have been implicated in triggering assembly. Here, we have explored the composition of Lewy bodies in post-mortem tissue using electron microscopy and immunogold labeling and revealed dityrosine crosslinks in Lewy bodies in brain tissue from PD patients. In vitro, we show that dityrosine cross-links in α-syn are formed by covalent ortho-ortho coupling of two tyrosine residues under conditions of oxidative stress by fluorescence and confirmed using mass-spectrometry. A covalently cross-linked dimer isolated by SDS-PAGE and mass analysis showed that dityrosine dimer was formed via the coupling of Y39-Y39 to give a homo dimer peptide that may play a key role in formation of oligomeric and seeds for fibril formation. Atomic force microscopy analysis reveals that the covalent dityrosine contributes to the stabilization of α-syn assemblies. Thus, the presence of oxidative stress induced dityrosine could play an important role in assembly and toxicity of α-syn in PD.
Subject(s)
Lewy Bodies/metabolism , Parkinson Disease/pathology , Tyrosine/analogs & derivatives , alpha-Synuclein/metabolism , Aged , Aged, 80 and over , Amino Acid Sequence , Brain/metabolism , Copper/chemistry , Dimerization , Electrophoresis, Polyacrylamide Gel , Humans , Male , Microscopy, Atomic Force , Microscopy, Electron, Transmission , Oxidation-Reduction , Oxidative Stress , Parkinson Disease/metabolism , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Tandem Mass Spectrometry , Tyrosine/analysis , Tyrosine/chemistry , alpha-Synuclein/chemistry , alpha-Synuclein/geneticsABSTRACT
Many peptides self-assemble to form amyloid fibrils. We previously explored the sequence propensity to form amyloid using variants of a designed peptide with sequence KFFEAAAKKFFE. These variant peptides form highly stable amyloid fibrils with varied lateral assembly and are ideal to template further assembly of non-proteinaceous material. Herein, we show that the fibrils formed by peptide variants can be coated with a layer of silica to produce silica nanowires using tetraethyl-orthosilicate. The resulting nanowires were characterized using electron microscopy (TEM), X-ray fiber diffraction, FTIR and cross-section EM to reveal a nanostructure with peptidic core. Lysine residues play a role in templating the formation of silica on the fibril surface and, using this library of peptides, we have explored the contributions of lysine as well as arginine to silica templating, and find that sequence plays an important role in determining the physical nature and structure of the resulting nanowires.
ABSTRACT
Amyloid beta (AĆ) induced neuronal death has been linked to memory loss, perhaps the most devastating symptom of Alzheimer's disease (AD). Although AĆ-induced impairment of synaptic or intrinsic plasticity is known to occur before any cell death, the links between these neurophysiological changes and the loss of specific types of behavioral memory are not fully understood. Here we used a behaviorally and physiologically tractable animal model to investigate AĆ-induced memory loss and electrophysiological changes in the absence of neuronal death in a defined network underlying associative memory. We found similar behavioral but different neurophysiological effects for AĆ 25-35 and AĆ 1-42 in the feeding circuitry of the snail Lymnaea stagnalis. Importantly, we also established that both the behavioral and neuronal effects were dependent upon the animals having been classically conditioned prior to treatment, since AĆ application before training caused neither memory impairment nor underlying neuronal changes over a comparable period of time following treatment.
Subject(s)
Amyloid beta-Peptides/metabolism , Memory, Long-Term , Neuronal Plasticity , Neurons/metabolism , Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/administration & dosage , Amyloid beta-Peptides/pharmacology , Animals , Apoptosis/drug effects , Behavior, Animal , Brain/drug effects , Brain/metabolism , Brain/pathology , Cell Death/drug effects , Conditioning, Classical , Electrophysiological Phenomena/drug effects , Hemolymph/metabolism , Memory Disorders/metabolism , Memory, Long-Term/drug effects , Neurons/drug effects , Protein Aggregation, Pathological , Snails , Time FactorsABSTRACT
Prion-like propagation of tau aggregation might underlie the stereotyped progression of neurodegenerative tauopathies. True prions stably maintain unique conformations ("strains") in vivo that link structure to patterns of pathology. We now find that tau meets this criterion. Stably expressed tau repeat domain indefinitely propagates distinct amyloid conformations in a clonal fashion in culture. Reintroduction of tau from these lines into naive cells reestablishes identical clones. We produced two strains in vitro that induce distinct pathologies in vivo as determined by successive inoculations into three generations of transgenic mice. Immunopurified tau from these mice recreates the original strains in culture. We used the cell system to isolate tau strains from 29 patients with 5 different tauopathies, finding that different diseases are associated with different sets of strains. Tau thus demonstrates essential characteristics of a prion. This might explain the phenotypic diversity of tauopathies and could enable more effective diagnosis and therapy.
Subject(s)
Hippocampus/pathology , Neurodegenerative Diseases/pathology , Prions/physiology , Tauopathies/pathology , tau Proteins/physiology , Animals , Disease Progression , HEK293 Cells , Hippocampus/physiology , Humans , Mice , Mice, Transgenic , Plaque, Amyloid/pathology , Tauopathies/geneticsABSTRACT
BACKGROUND: Alzheimer's disease (AD) is characterized by the deposition of insoluble amyloid plaques in the neuropil composed of highly stable, self-assembled Amyloid-beta (AĆ) fibrils. Copper has been implicated to play a role in Alzheimer's disease. Dimers of AĆ have been isolated from AD brain and have been shown to be neurotoxic. RESULTS: We have investigated the formation of dityrosine cross-links in AĆ42 formed by covalent ortho-ortho coupling of two tyrosine residues under conditions of oxidative stress with elevated copper and shown that dityrosine can be formed in vitro in AĆ oligomers and fibrils and that these links further stabilize the fibrils. Dityrosine crosslinking was present in internalized AĆ in cell cultures treated with oligomeric AĆ42 using a specific antibody for dityrosine by immunogold labeling transmission electron microscopy. Results also revealed the prevalence of dityrosine crosslinks in amyloid plaques in brain tissue and in cerebrospinal fluid from AD patients. CONCLUSIONS: AĆ dimers may be stabilized by dityrosine crosslinking. These results indicate that dityrosine cross-links may play an important role in the pathogenesis of Alzheimer's disease and can be generated by reactive oxygen species catalyzed by Cu2+ ions. The observation of increased AĆ and dityrosine in CSF from AD patients suggests that this could be used as a potential biomarker of oxidative stress in AD.
Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Peptide Fragments/metabolism , Tyrosine/analogs & derivatives , Aged , Aged, 80 and over , Alzheimer Disease/pathology , Biomarkers/metabolism , Cells, Cultured , Copper/metabolism , Female , Humans , Male , Neuroblastoma , Oxidative Stress/physiology , Plaque, Amyloid/metabolism , Plaque, Amyloid/pathology , Tyrosine/metabolismABSTRACT
At small central synapses, efficient turnover of vesicles is crucial for stimulus-driven transmission, but how the structure of this recycling pool relates to its functional role remains unclear. Here we characterize the organizational principles of functional vesicles at native hippocampal synapses with nanoscale resolution using fluorescent dye labeling and electron microscopy. We show that the recycling pool broadly scales with the magnitude of the total vesicle pool, but its average size is small (Ć¢ĀĀ¼45 vesicles), highly variable, and regulated by CDK5/calcineurin activity. Spatial analysis demonstrates that recycling vesicles are preferentially arranged near the active zone and this segregation is abolished by actin stabilization, slowing the rate of activity-driven exocytosis. Our approach reveals a similarly biased recycling pool distribution at synapses in visual cortex activated by sensory stimulation inĀ vivo. We suggest that in small native central synapses, efficient release ofĀ a limited pool of vesicles relies on their favored spatial positioning within the terminal.
Subject(s)
Endocytosis/physiology , Hippocampus/metabolism , Synapses/metabolism , Synaptic Transmission/physiology , Synaptic Vesicles/metabolism , Animals , Hippocampus/ultrastructure , Mice , Mice, Inbred C57BL , Organ Culture Techniques , Photic Stimulation/methods , Rats , Synapses/ultrastructure , Synaptic Vesicles/ultrastructureABSTRACT
Fused in sarcoma (FUS)-immunoreactive neuronal and glial inclusions define a novel molecular pathology called FUS proteinopathy. FUS has been shown to be a component of inclusions of familial amyotrophic lateral sclerosis with FUS mutation and three frontotemporal lobar degeneration entities, including neuronal intermediate filament inclusion disease (NIFID). The pathogenic role of FUS is unknown. In addition to FUS, many neuronal cytoplasmic inclusions (NCI) of NIFID contain aggregates of α-internexin and neurofilament proteins. Herein, we have shown that: (1) FUS becomes relatively insoluble in NIFID and there are no apparent posttranslational modifications, (2) there are no pathogenic abnormalities in the FUS gene in NIFID, and (3) immunoelectron microscopy demonstrates the fine structural localization of FUS in NIFID which has not previously been described. FUS localized to euchromatin, and strongly with paraspeckles, in nuclei, consistent with its RNA/DNA-binding functions. NCI of varying morphologies were observed. Most frequent were the "loosely aggregated cytoplasmic inclusions," 81% of which had moderate or high levels of FUS immunoreactivity. Much rarer "compact cytoplasmic inclusions" and "tangled twine ball inclusions" were FUS-immunoreactive at their granular peripheries, or heavily FUS-positive throughout, respectively. Thus, FUS may aggregate in the cytoplasm and then admix with neuronal intermediate filament accumulations.
Subject(s)
Frontotemporal Lobar Degeneration/pathology , Immunohistochemistry , Inclusion Bodies/pathology , Intermediate Filaments/pathology , Microscopy, Electron, Transmission/methods , Microscopy, Immunoelectron/methods , Neurons/pathology , RNA-Binding Protein FUS/metabolism , Adult , Aged , Brain/pathology , Female , Frontotemporal Lobar Degeneration/metabolism , Humans , Intermediate Filaments/metabolism , Male , Middle Aged , Neurofilament Proteins/metabolismABSTRACT
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that results in the death of motor neurons in the brain and spinal cord. The disorder generally strikes in mid-life, relentlessly leading to paralysis and death, typically 3-5 years after diagnosis. No effective treatments are available. Up to 10% of ALS is familial, usually autosomal dominant. Several causative genes are known and, of these, mutant superoxide dismutase 1 (SOD1) is by far the most frequently found, accounting for up to 20% of familial ALS. A range of human mutant SOD1 transgenic mouse strains has been produced, and these largely successfully model the human disease. Of these, the most widely used is the SOD1 mouse, which expresses a human SOD1 transgene with a causative G93A mutation. This mouse model is excellent for many purposes but carries up to 25 copies of the transgene and produces a great excess of SOD1 protein, which might affect our interpretation of disease processes. A variant of this strain carries a deletion of the transgene array such that the copy number is dropped to eight to ten mutant SOD1 genes. This 'deleted' 'low-copy' mouse undergoes a slower course of disease, over many months. Here we have carried out a comprehensive analysis of phenotype, including nerve and muscle physiology and histology, to add to our knowledge of this 'deleted' strain and give baseline data for future studies. We find differences in phenotype that arise from genetic background and sex, and we quantify the loss of nerve and muscle function over time. The slowly progressive pathology observed in this mouse strain could provide us with a more appropriate model for studying early-stage pathological processes in ALS and aid the development of therapies for early-stage treatments.
Subject(s)
Amino Acid Substitution/genetics , Amyotrophic Lateral Sclerosis/pathology , Disease Models, Animal , Gene Dosage/genetics , Superoxide Dismutase/genetics , Amyotrophic Lateral Sclerosis/complications , Amyotrophic Lateral Sclerosis/physiopathology , Animals , Behavior, Animal , Cell Survival , Disease Progression , Endpoint Determination , Female , Gliosis/complications , Gliosis/pathology , Gliosis/physiopathology , Hand Strength/physiology , Hindlimb/pathology , Hindlimb/physiopathology , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Motor Neurons/pathology , Muscles/pathology , Muscles/physiopathology , Protein Folding , Reflex, Startle/physiology , Rotarod Performance Test , Sex Characteristics , Spinal Cord/pathology , Spinal Cord/physiopathology , Spinal Cord/ultrastructure , Superoxide Dismutase-1ABSTRACT
The major human neurodegenerative diseases are characterised by ubiquitin-positive intraneuronal inclusions, however the precise nature of the ubiquitin modifications in these structures is unclear. Using a monoclonal antibody specific for Lys63-linked polyubiquitin we have performed the first immunohistochemical analysis of linkage-specific ubiquitination in vivo associated with neurodegeneration. Immunoreactivity was detected within the pathological lesions of Alzheimer's, Huntington's and Parkinson's disease brains, although staining of Lewy bodies in the substantia nigra in Parkinson's disease was rare, indicating a selective involvement of Lys63-linked polyubiquitin in inclusion biogenesis in this disorder. Immunoreactivity was also a feature in neurons of proteasome-depleted mice, suggesting a proteasomal contribution to the degradation of Lys63-linked polyubiquitinated proteins in vivo.
Subject(s)
Lysine/metabolism , Neurodegenerative Diseases/metabolism , Polyubiquitin/metabolism , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Animals , Brain/metabolism , Brain/pathology , Humans , Huntington Disease/metabolism , Huntington Disease/pathology , Immunohistochemistry , Lewy Bodies/metabolism , Mice , Neurodegenerative Diseases/pathology , Neurons/metabolism , Parkinson Disease/metabolism , Parkinson Disease/pathology , Proteasome Endopeptidase Complex/metabolismABSTRACT
TAR DNA-binding protein of 43 kDa (TDP-43) is a major component of the pathological inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy, also called FTLD with ubiquitin-positive, tau-negative inclusions (FTLD-U), and motor neuron disease (MND). TDP-43 is predominantly expressed in the nucleus and regulates gene expression and splicing. In FTLD with TDP-43 proteinopathy, neuronal inclusions present variably as cytoplasmic inclusions (NCIs), dystrophic neurites (DNs), and intranuclear inclusions (NIIs), leading to a fourfold neuropathological classification correlating with genotype. There have been few fine structural studies of these inclusions. Thus, we undertook an immunoelectron microscopic study of FTLD with TDP-43 proteinopathy, including sporadic and familial cases with progranulin (GRN) mutation. TDP-43-immunoreactive inclusions comprised two components: granular and filamentous. Filament widths, expressed as mean (range) were: NCI, 9 nm (4-16 nm); DN, 10 nm (5-16 nm); NII, 18 nm (9-50 nm). Morphologically distinct inclusion components may reflect the process of TDP-43 aggregation and interaction with other proteins: determining these latter may contribute towards understanding the heterogeneous pathogenesis of FTLD with TDP-43 proteinopathy.
Subject(s)
Brain/pathology , DNA-Binding Proteins/metabolism , Dementia/pathology , Genetic Predisposition to Disease/genetics , Inclusion Bodies/pathology , Neurons/pathology , Aged , Aged, 80 and over , Brain/metabolism , Brain/physiopathology , Cell Nucleus/metabolism , Cell Nucleus/pathology , Cytoplasm/metabolism , Cytoplasm/pathology , DNA Mutational Analysis , DNA-Binding Proteins/genetics , Dementia/genetics , Dementia/metabolism , Female , Genetic Testing , Humans , Inclusion Bodies/genetics , Inclusion Bodies/metabolism , Intercellular Signaling Peptides and Proteins/genetics , Male , Microscopy, Immunoelectron , Mutation/genetics , Neurons/metabolism , ProgranulinsABSTRACT
Abnormal neuronal cytoplasmic inclusions (NCIs) containing aggregates of alpha-internexin and the neurofilament (NF) subunits, NF-H, NF-M, and NF-L, are the signature lesions of neuronal intermediate filament (IF) inclusion disease (NIFID). The disease has a clinically heterogeneous phenotype, including frontotemporal dementia, pyramidal and extrapyramidal signs presenting at a young age. NCIs are variably ubiquitinated and about half of cases also have neuronal intranuclear inclusions (NIIs), which are also ubiquitinated. NIIs have been described in polyglutamine-repeat expansion diseases, where they are strongly ubiquitin immunoreactive. The fine structure of NIIs of NIFID has not previously been described. Therefore, to determine the ultrastructure of NIIs, immunoelectron microscopy was undertaken on NIFID cases and normal aged control brains. Our results indicate that the NIIs of NIFID are strongly ubiquitin immunoreactive. However, unlike NCIs which contain ubiquitin, alpha-internexin and NF epitopes, NIIs contain neither epitopes of alpha-internexin nor NF subunits. Neither NIIs nor NCIs were recognised by antibodies to expanded polyglutamine repeats. The NII of NIFID lacks a limiting membrane and contains straight filaments of 20 nm mean width (range 11-35 nm), while NCIs contain filaments with a mean width of 10 nm (range 5-18 nm; t-test, P<0.001). Biochemistry revealed no differences in neuronal IF protein mobilities between NIFID and normal brain tissue. Therefore, NIIs of NIFID contain filaments morphologically and immunologically distinct from those of NCIs, and both types of inclusion lack expanded polyglutamine tracts of the triplet-repeat expansion diseases. These observations indicate that abnormal protein aggregation follows separate pathways in different neuronal compartments of NIFID.
Subject(s)
Inclusion Bodies/metabolism , Inclusion Bodies/ultrastructure , Intermediate Filaments/metabolism , Intermediate Filaments/ultrastructure , Adult , Aged , Female , Humans , Inclusion Bodies/pathology , Intermediate Filament Proteins/metabolism , Intermediate Filaments/pathology , Male , Microscopy, Electron, Transmission/methods , Microscopy, Immunoelectron , Middle AgedABSTRACT
BACKGROUND: The recruitment of mRNA for translation involves the assembly at the 5'cap of a complex of three initiation factors: the cap binding protein eIF4E, the ATP-dependent RNA helicase eIF4A and the scaffold protein eIF4G. eIF4G mediates the binding of this mRNA-protein complex to the 43S ribosomal preinitiation complex. There is growing recognition that the components of the translational apparatus interact functionally with cytoskeletal components. Here we report specific effects of the over-expression of human and fission yeast eIF4G domains on cell morphology in Schizosaccharomyces pombe. RESULTS: A single gene encoding fission yeast eIF4G was identified and demonstrated to be essential. We have over-expressed fragments corresponding to the conserved functional domains of eIF4G. At expression levels that did not disrupt rates of overall translation or protein accumulation, a fragment of S. pombe eIF4G, 4G-NOB, corresponding to the minimal region of human eIF4G required to support cap-independent mRNA recruitment, was found to impair cell proliferation in fission yeast. This resulted from defects in cytokinesis, and was associated with the disruption of both microtubules and actin microfilaments. The over-expressed fragment was itself localized to the cell ends, the nuclear periphery and the septum. CONCLUSIONS: This is the first demonstration of a link between a translation initiation factor and mechanisms controlling cell morphology. The data suggest a direct or indirect interaction between the functional domains of eIF4G and cellular structures involved in cytokinesis.
Subject(s)
Actins/metabolism , Eukaryotic Initiation Factor-4G/chemistry , Eukaryotic Initiation Factor-4G/metabolism , Fungal Proteins/metabolism , Microtubules/metabolism , Protein Biosynthesis , Schizosaccharomyces/metabolism , Amino Acid Sequence , Binding Sites , Cell Survival , Eukaryotic Initiation Factor-4G/genetics , Fungal Proteins/chemistry , Green Fluorescent Proteins , Humans , Luminescent Proteins/metabolism , Molecular Sequence Data , Recombinant Fusion Proteins/metabolism , Schizosaccharomyces/genetics , Schizosaccharomyces/ultrastructure , Sequence Homology, Amino AcidABSTRACT
The peptidyl-prolyl cis-trans isomerase (PPIase) Pin1 modulates the activity of a range of target proteins involved in the cell cycle, transcription, translation, endocytosis, and apoptosis by facilitating dephosphorylation of phosphorylated serine or threonine residue preceding a proline (p-Ser/Thr-Pro) motifs catalyzed by phosphatases specific for the trans conformations. Pin1 targets include the neuronal microtubule-associated protein tau, whose dephosphorylation restores its ability to stabilize microtubules. We, and others, have shown that tau hyperphosphorylation in the neurofibrillary tangles (NFTs) of Alzheimer disease (AD) is associated with redirection of the predominantly nuclear Pin1 to the cytoplasm and with Pin1 shortfalls throughout subcellular compartments. As nuclear Pin1 depletion causes apoptosis, shortfalls in regard to both nuclear and p-tau targets may contribute to neuronal dysfunction. We report here that similar Pin1 redistribution and shortfalls occur in frontotemporal dementias (FTDs) characterized by abnormal protein aggregates of tau and other cytoskeletal proteins. This may be a unifying, contributory factor towards neuronal death in these dementias.